» 모두 » 주식 예측 » Trevi Therapeutics Inc. Common Stock 예측

Trevi Therapeutics Inc. Common Stock 예측: 내일, 주, 월, 5년

업데이트됨: April 22 · 2026 at 07:03 UTC
▼ -5.07%Market Cap $1.88B · Technical analysis Bearish · Focus area Price + volatility

예측 요약

기간예상 가격과거역사적인통찰력
내일$14.85 +1.59%어제$14.52 -0.67%Tomorrow's Trevi Therapeutics Inc. Common Stock (TRVI) setup is anchored to $14.62 and targets $14.85 (+1.59%). The near-term read is upside; watch $15.06 / $14.18 because daily realized volatility is about 8.00%.
Tomorrow's Trevi Therapeutics Inc. Common Stock (TRVI) setup is anchored to $14.62 and targets $14.85 (+1.59%). The near-term read is upside; watch $15.06 / $14.18 because daily realized volatility is about 8.00%.
$15.34 +4.95%지난주$14.32 -2.08%The 7-day Trevi Therapeutics Inc. Common Stock model moves from $14.32 to $15.34 (+4.95%). It gives upside momentum context for this stock, so breaks around $15.06 / $14.18 matter more than a single tick.
The 7-day Trevi Therapeutics Inc. Common Stock model moves from $14.32 to $15.34 (+4.95%). It gives upside momentum context for this stock, so breaks around $15.06 / $14.18 matter more than a single tick.
$16.16 +10.54%전달$13.97 -4.43%The 1-month Trevi Therapeutics Inc. Common Stock target is $16.16 (+10.54%), compared with the live reference near $14.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Trevi Therapeutics Inc. Common Stock target is $16.16 (+10.54%), compared with the live reference near $14.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도$17.39 +18.93%작년$13.46 -7.95%The 1-year Trevi Therapeutics Inc. Common Stock scenario points to $17.39 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Trevi Therapeutics Inc. Common Stock scenario points to $17.39 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년$20.26 +38.57%5년 전$12.25 -16.20%The 5-year Trevi Therapeutics Inc. Common Stock view is $20.26 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Trevi Therapeutics Inc. Common Stock view is $20.26 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
내일$14.85 +1.59%
어제$14.52 -0.67%
Tomorrow's Trevi Therapeutics Inc. Common Stock (TRVI) setup is anchored to $14.62 and targets $14.85 (+1.59%). The near-term read is upside; watch $15.06 / $14.18 because daily realized volatility is about 8.00%.
$15.34 +4.95%
지난주$14.32 -2.08%
The 7-day Trevi Therapeutics Inc. Common Stock model moves from $14.32 to $15.34 (+4.95%). It gives upside momentum context for this stock, so breaks around $15.06 / $14.18 matter more than a single tick.
$16.16 +10.54%
전달$13.97 -4.43%
The 1-month Trevi Therapeutics Inc. Common Stock target is $16.16 (+10.54%), compared with the live reference near $14.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도$17.39 +18.93%
작년$13.46 -7.95%
The 1-year Trevi Therapeutics Inc. Common Stock scenario points to $17.39 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년$20.26 +38.57%
5년 전$12.25 -16.20%
The 5-year Trevi Therapeutics Inc. Common Stock view is $20.26 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

가격 차트

역사적인예측강세약세
$15.65$15.23$14.80$14.38$13.951W AgoNow7D F

기술적 분석

팔다중립적구입하다
Neutral
1
강세
3
중립적
1
약세

주요 지표

지시자신호
Price$14.62 Mid
Daily Change-5.07% Below
Volatility Cap20.0% Mid
Confidence68% Above
Data Sourcenasdaq-screener Mid

과거 데이터

Current$14.62
Daily Change-5.07%
Market Cap$1.88B
Sourcenasdaq-screener
Current$14.62Daily Change-5.07%
Market Cap$1.88BSourcenasdaq-screener

지지 및 저항 수준

$14.18Support 1
$14.62현재의
$15.06Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

가격 이정표

주요 수준 및 역사적 맥락
Current$14.62Live reference price
Used as the anchor for generated forecast calculations.
Next Month$16.16Model projection+10.54%
Directional scenario based on capped drift.

예측 정확도

우리 모델의 성능
68%
방향성
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
우리의 알고리즘은 최신 가격 조치, 변동성 체제 및 지표 신호를 사용하여 매주 재보정됩니다. 정확도는 기간에 따라 다릅니다. 단기적인 모멘텀이 장기 예측보다 더 안정적입니다.
Short term
68%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

투자 시나리오

오늘 TRVI에 $1,000를 투자한다면
Bullish Scenario
$15.35
+5.00% from current
목표가격$15.35
대본Upside momentum
개연성60%
Base Scenario
$16.16
+10.54%
목표가격$16.16
대본Capped drift
개연성68%
Bearish Scenario
$13.89
-5.00% from current
목표가격$13.89
대본Volatility drawdown
개연성32%
기초: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

예측 요인

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 72/100
24H drift+1.59%
7D drift+4.95%
30D drift+10.54%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 69/100
1M outlook+10.54%
1Y outlook+18.93%
5Y outlook+38.57%

자주 묻는 질문

Q What is the Trevi Therapeutics Inc. Common Stock (TRVI) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Trevi Therapeutics Inc. Common Stock is projected near $14.85 versus the current reference around $14.62. That implies a modeled move of +1.59% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for TRVI?
The weekly Trevi Therapeutics Inc. Common Stock model points to $15.34, which maps to an expected drift of +4.95% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Trevi Therapeutics Inc. Common Stock 1-month and 1-year targets?
The Trevi Therapeutics Inc. Common Stock 1-month target is $16.16 (+10.54%), while the 1-year target is $17.39 (+18.93%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Trevi Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The Trevi Therapeutics Inc. Common Stock long-horizon scenario sits near $20.26 with a modeled change of +38.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are TRVI support and resistance zones right now?
For Trevi Therapeutics Inc. Common Stock, nearest resistance is around $14.18, while nearest support is around $15.06. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Trevi Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.